Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth

被引：0
|
作者：
Yuzhu Wang
Tao He
James G. Herman
Enqiang Linghu
Yunsheng Yang
François Fuks
Fuyou Zhou
Linjie Song
Mingzhou Guo
机构：
[1] Chinese PLA General Hospital,Department of Gastroenterology & Hepatology
[2] Chinese PLA Navy General Hospital,Department of Geriatric Digestive System
[3] University of Pittsburgh Cancer Institute,The Hillman Cancer Center
[4] Free University of Brussels (U.L.B.),Laboratory of Cancer Epigenetics
[5] Anyang Tumor Hospital,Department of Thoracic Surgery
[6] Chinese PLA General Hospital,Department of General Surgery
[7] Medical College of NanKai University,undefined
来源：
Clinical Epigenetics | 2018年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Zyxin as a potential cancer prognostic marker promotes the proliferation and metastasis of colorectal cancer cells
    Zhong, Chenhan
    Yu, Jiekai
    Li, Dan
    Jiang, Kai
    Tang, Yang
    Yang, Mengyuan
    Shen, Hong
    Fang, Xuefeng
    Ding, Kefeng
    Zheng, Shu
    Yuan, Ying
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 15775 - 15789
  • [22] Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
    R Bertorelle
    M Briarava
    E Rampazzo
    L Biasini
    M Agostini
    I Maretto
    S Lonardi
    M L Friso
    C Mescoli
    V Zagonel
    D Nitti
    A De Rossi
    S Pucciarelli
    British Journal of Cancer, 2013, 108 : 278 - 284
  • [23] Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
    Bertorelle, R.
    Briarava, M.
    Rampazzo, E.
    Biasini, L.
    Agostini, M.
    Maretto, I.
    Lonardi, S.
    Friso, M. L.
    Mescoli, C.
    Zagonel, V.
    Nitti, D.
    De Rossi, A.
    Pucciarelli, S.
    BRITISH JOURNAL OF CANCER, 2013, 108 (02) : 278 - 284
  • [24] Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer
    Lin, BR
    Chang, CC
    Che, TF
    Chen, ST
    Chen, RJC
    Yang, CY
    Jeng, YM
    Liang, JT
    Lee, PH
    Chang, KJ
    Chau, YP
    Kuo, ML
    GASTROENTEROLOGY, 2005, 128 (01) : 9 - 23
  • [25] IGFBP3 Methylation As a Novel Diagnostic and Prognostic Marker in Colorectal Cancer
    Perez-Carbonell, Lucia
    Toiyama, Yuji
    Balaguer, Francesc
    Guarinos, Carla
    Hur, Keun
    Andreu, Montserrat
    Llor, Xavier
    Castells, Antoni
    Jover, Rodrigo
    Boland, C. Richard
    Goel, Ajay
    GASTROENTEROLOGY, 2013, 144 (05) : S356 - S356
  • [26] Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
    U Wallin
    B Glimelius
    K Jirström
    S Darmanis
    R Y Nong
    F Pontén
    C Johansson
    L Påhlman
    H Birgisson
    British Journal of Cancer, 2011, 104 : 1619 - 1627
  • [27] Serum vascular endothelial growth factor: A prognostic marker in colorectal cancer
    Chin, KF
    Kumar, H
    Greenman, J
    Hartley, J
    Kerin, MJ
    Monson, J
    BRITISH JOURNAL OF CANCER, 1999, 80 : 88 - 88
  • [28] Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
    Wallin, U.
    Glimelius, B.
    Jirstrom, K.
    Darmanis, S.
    Nong, R. Y.
    Ponten, F.
    Johansson, C.
    Pahlman, L.
    Birgisson, H.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1619 - 1627
  • [29] Neuropeptide Y as a prognostic marker of colorectal cancer
    Sarkar, Chandrani
    Chakroborty, Debanjan
    CANCER RESEARCH, 2014, 74 (19)
  • [30] Arylsulfatase B as prognostic marker in colorectal cancer
    Kovacs, Z.
    Banias, L.
    Jung, I.
    Gurzu, S.
    VIRCHOWS ARCHIV, 2019, 475 : S272 - S272
12345